Vaidya Sane

{
  "main_header": {
    "sid": 1003610,
    "name": "Vaidya Sane",
    "stock_name": "Vaidya Sane",
    "full_name": "Vaidya Sane Ayurved Laboratories Ltd",
    "name_url": "stocks-analysis/vaidya-sane",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "234.05",
    "chg": -11.3,
    "chgp": "-4.61%",
    "dir": -1,
    "prev_price": "245.35",
    "mcapval": "253.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "MADHAVBAUG",
    "ind_name": "Hospital",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0JR301013",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": 16800,
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vaidya-sane-1003610-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Vaidya Sane Ayurved Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vaidya-sane-ayurved-laboratories-ltd-fallingrising-3787772",
        "imagepath": "",
        "date": "2026-01-10 01:38:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>The stock’s recent price action reveals a clear short-term weakness. Over the past week, the share price has declined by 8.47%, significantly underperforming the Sensex’s 2.45% fall during the same period. Similarly, the one-month return shows a 3.36% decrease against the Sensex’s modest 0.61% decline. Year-to-date, the stock has dropped 8.65%, while the benchmark index has fallen by only 1.71%. This pattern indicates that the stock is currently facing selling pressure beyond general market trends.</p>\n<p>On the day in question, the stock underperformed its sector by 2.43%, suggesting that sector-specific factors or company-related developments may be influencing investor sentiment negatively. The share price is trading below its s..."
      },
      {
        "title": "Vaidya Sane Ayurved Laboratories Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vaidya-sane-ayurved-laboratories-ltd-is-rated-hold-3781641",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VaidyaSaneAyurv_mojoScore_3781641.png",
        "date": "2026-01-05 10:11:38",
        "description": "Vaidya Sane Ayurved Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Vaidya Sane Ayurved Laboratories Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vaidya-sane-ayurved-laboratories-ltd-is-rated-hold-3769395",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VaidyaSaneAyurv_mojoScore_3769395.png",
        "date": "2025-12-25 12:57:11",
        "description": "Vaidya Sane Ayurved Laboratories Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 03 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of its performance and prospects."
      },
      {
        "title": "Vaidya Sane Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vaidya-sane-upgraded-from-sell-to-hold-by-marketsmojo-on-3-june-2025-3743969",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VaidyaSane_mojoScore_3743969.png",
        "date": "2025-12-03 11:08:25",
        "description": "Vaidya Sane, a microcap player in the hospital sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This adjustment comes amid a backdrop of strong year-to-date returns and a complex financial and technical profile, prompting investors to reassess the stock’s positioning within its sector."
      },
      {
        "title": "Is Vaidya Sane overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-vaidya-sane-overvalued-or-undervalued-3678258",
        "imagepath": "",
        "date": "2025-11-07 08:14:34",
        "description": "As of 6 November 2025, the valuation grade for Vaidya Sane has moved from expensive to very expensive. The company is currently considered overvalued. Key ratios include a PE ratio of 48.20, an EV to EBITDA of 26.00, and a PEG ratio of 0.11, which indicates a significant premium compared to its peers.\n\nIn comparison to its industry peers, Sun Pharma has a PE ratio of 35.02 and an EV to EBITDA of 10.54, while Cipla is valued more attractively with a PE ratio of 22.27 and an EV to EBITDA of 5.53. Despite Vaidya Sane's strong year-to-date return of 90.47%, which outperforms the Sensex's 7.89%, the current valuation metrics suggest that the stock is not justified at its price level...."
      },
      {
        "title": "How has been the historical performance of Vaidya Sane?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-vaidya-sane-3677372",
        "imagepath": "",
        "date": "2025-11-06 23:04:18",
        "description": "Answer:\nThe historical performance of Vaidya Sane shows a significant growth trajectory, particularly from fiscal year Mar'22 to Mar'25.\n\nBreakdown:\nVaidya Sane's net sales increased from zero in Mar'22 to 89.85 Cr in Mar'25, although there was a decline from 99.33 Cr in Mar'24. Total operating income followed a similar trend, rising from zero to 89.85 Cr, with a slight decrease from the previous year. The company managed to reduce its total expenditure from 94.83 Cr in Mar'24 to 76.34 Cr in Mar'25, contributing to an operating profit (PBDIT) of 15.37 Cr in Mar'25, up from 6.25 Cr in Mar'24. Profit before tax also saw a notable increase, reaching 9.90 Cr in Mar'25 compared to 2.86 Cr in Mar'24, while profit after tax rose to 7.15 Cr from 1.99 Cr. The earnings per share (EPS) improved significantly from 1.88 in Mar'24 to 6.79 in Mar'25. On the balance sheet, total liabilities increased from 54.81 Cr in Mar'2..."
      },
      {
        "title": "Why is Vaidya Sane falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vaidya-sane-fallingrising-3657008",
        "imagepath": "",
        "date": "2025-10-29 23:36:13",
        "description": "As of 29-Oct, Vaidya Sane Ayurved Laboratories Ltd is experiencing a price increase, currently at 274.95, reflecting a rise of 2.95 or 1.08%. The stock has shown strong performance today, outperforming its sector by 0.34%. Additionally, it has higher moving averages compared to the 5-day, 20-day, 100-day, and 200-day averages, although it is lower than the 50-day moving average. Notably, there has been a significant increase in investor participation, with delivery volume rising by 61.76% against the 5-day average. The stock has also demonstrated impressive returns over various periods, including a year-to-date increase of 98.45% and a one-year increase of 94.52%, indicating strong overall performance despite a slight decline of 1.80% over the past month.\n\nIn the broader market context, Vaidya Sane's short-term return of +6.98% over the past week significantly outpaces the benchmark Sensex, which has only i..."
      },
      {
        "title": "Vaidya Sane Ayurved Laboratories Ltd Surges 3.85% Today, Up 94.88% Year-to-Date",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vaidya-sane-ayurved-laboratories-ltd-surges-385-today-up-9488-year-to-date-3643834",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/VaidyaSaneAyurv_only_buyers_3643834.png",
        "date": "2025-10-24 11:41:14",
        "description": "Vaidya Sane Ayurved Laboratories Ltd is experiencing notable buying interest, with a significant rise in its stock price today. Over the past week, month, and year, the company has outperformed the Sensex, reflecting strong momentum and positive sentiment in the microcap hospital sector."
      },
      {
        "title": "Vaidya Sane Ayurved Laboratories Stock Hits Upper Circuit at Rs 273.0, Up 5%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vaidya-sane-ayurved-laboratories-stock-hits-upper-circuit-at-rs-2730-up-5-3643755",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/VaidyaSaneAyurv_stocks_hitting_upper_circuit_3643755.png",
        "date": "2025-10-24 11:00:16",
        "description": "Vaidya Sane Ayurved Laboratories Ltd, a microcap in the hospital sector, saw significant trading activity today, reaching its upper circuit limit. The stock outperformed its sector and the Sensex, with notable trading volume and turnover. Despite a drop in delivery volume, liquidity remains adequate, indicating positive market sentiment."
      }
    ],
    "total": 4817,
    "sid": "1003610",
    "stock_news_url": "https://www.marketsmojo.com/news/vaidya-sane-ayurved-laboratories-1003610"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Vaidya Sane Ayurved Laboratories Ltd has declared <strong>2%</strong> dividend, ex-date: 05 Sep 23",
          "dt": "2023-09-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Vaidya Sane Ayurved Laboratories Ltd falling/rising?

2026-01-10 01:38:16

Short-Term Price Movement and Market Context

The stock’s recent price action reveals a clear short-term weakness. Over the past week, the share price has declined by 8.47%, significantly underperforming the Sensex’s 2.45% fall during the same period. Similarly, the one-month return shows a 3.36% decrease against the Sensex’s modest 0.61% decline. Year-to-date, the stock has dropped 8.65%, while the benchmark index has fallen by only 1.71%. This pattern indicates that the stock is currently facing selling pressure beyond general market trends.

On the day in question, the stock underperformed its sector by 2.43%, suggesting that sector-specific factors or company-related developments may be influencing investor sentiment negatively. The share price is trading below its s...

Read full news article

Vaidya Sane Ayurved Laboratories Ltd is Rated Hold

2026-01-05 10:11:38

Vaidya Sane Ayurved Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Vaidya Sane Ayurved Laboratories Ltd is Rated Hold

2025-12-25 12:57:11

Vaidya Sane Ayurved Laboratories Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 03 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of its performance and prospects.

Read full news article

Vaidya Sane Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-03 11:08:25

Vaidya Sane, a microcap player in the hospital sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This adjustment comes amid a backdrop of strong year-to-date returns and a complex financial and technical profile, prompting investors to reassess the stock’s positioning within its sector.

Read full news article

Is Vaidya Sane overvalued or undervalued?

2025-11-07 08:14:34

As of 6 November 2025, the valuation grade for Vaidya Sane has moved from expensive to very expensive. The company is currently considered overvalued. Key ratios include a PE ratio of 48.20, an EV to EBITDA of 26.00, and a PEG ratio of 0.11, which indicates a significant premium compared to its peers. In comparison to its industry peers, Sun Pharma has a PE ratio of 35.02 and an EV to EBITDA of 10.54, while Cipla is valued more attractively with a PE ratio of 22.27 and an EV to EBITDA of 5.53. Despite Vaidya Sane's strong year-to-date return of 90.47%, which outperforms the Sensex's 7.89%, the current valuation metrics suggest that the stock is not justified at its price level....

Read full news article

How has been the historical performance of Vaidya Sane?

2025-11-06 23:04:18

Answer: The historical performance of Vaidya Sane shows a significant growth trajectory, particularly from fiscal year Mar'22 to Mar'25. Breakdown: Vaidya Sane's net sales increased from zero in Mar'22 to 89.85 Cr in Mar'25, although there was a decline from 99.33 Cr in Mar'24. Total operating income followed a similar trend, rising from zero to 89.85 Cr, with a slight decrease from the previous year. The company managed to reduce its total expenditure from 94.83 Cr in Mar'24 to 76.34 Cr in Mar'25, contributing to an operating profit (PBDIT) of 15.37 Cr in Mar'25, up from 6.25 Cr in Mar'24. Profit before tax also saw a notable increase, reaching 9.90 Cr in Mar'25 compared to 2.86 Cr in Mar'24, while profit after tax rose to 7.15 Cr from 1.99 Cr. The earnings per share (EPS) improved significantly from 1.88 in Mar'24 to 6.79 in Mar'25. On the balance sheet, total liabilities increased from 54.81 Cr in Mar'2...

Read full news article

Why is Vaidya Sane falling/rising?

2025-10-29 23:36:13

As of 29-Oct, Vaidya Sane Ayurved Laboratories Ltd is experiencing a price increase, currently at 274.95, reflecting a rise of 2.95 or 1.08%. The stock has shown strong performance today, outperforming its sector by 0.34%. Additionally, it has higher moving averages compared to the 5-day, 20-day, 100-day, and 200-day averages, although it is lower than the 50-day moving average. Notably, there has been a significant increase in investor participation, with delivery volume rising by 61.76% against the 5-day average. The stock has also demonstrated impressive returns over various periods, including a year-to-date increase of 98.45% and a one-year increase of 94.52%, indicating strong overall performance despite a slight decline of 1.80% over the past month. In the broader market context, Vaidya Sane's short-term return of +6.98% over the past week significantly outpaces the benchmark Sensex, which has only i...

Read full news article

Vaidya Sane Ayurved Laboratories Ltd Surges 3.85% Today, Up 94.88% Year-to-Date

2025-10-24 11:41:14

Vaidya Sane Ayurved Laboratories Ltd is experiencing notable buying interest, with a significant rise in its stock price today. Over the past week, month, and year, the company has outperformed the Sensex, reflecting strong momentum and positive sentiment in the microcap hospital sector.

Read full news article

Vaidya Sane Ayurved Laboratories Stock Hits Upper Circuit at Rs 273.0, Up 5%

2025-10-24 11:00:16

Vaidya Sane Ayurved Laboratories Ltd, a microcap in the hospital sector, saw significant trading activity today, reaching its upper circuit limit. The stock outperformed its sector and the Sensex, with notable trading volume and turnover. Despite a drop in delivery volume, liquidity remains adequate, indicating positive market sentiment.

Read full news article

View All News